Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Effect of isoquinoline alkaloids from two Hippeastrum species on in vitro acetylcholinesterase activity
Author: Pagliosa, LB
Monteiro, SC
Silva, KB
de Andrade, JP
Dutilh, J
Bastida, J
Cammarota, M
Zuanazzi, JAS
Abstract: The treatment of neurological disorders and neurodegenerative diseases is related to the levels of acetylcholine (ACh) through the inhibition of acetylcholinesterase (AChE). Galanthamine, an important alkaloid isolated from the Amaryllidaceae family, is approved for the pharmacological treatment of Alzheimer's disease (AD) and acts by inhibiting the acetylcholinesterase (AChE) activity. In the present study, Ellman's method was used to verify the inhibition of AChE activity of some isoquinolines alkaloids such as galanthamine, montanine, hippeastrine and pretazettine. At the concentrations 1 mM, 500 mu m and 100 mu m, galanthamine presented an AChE inhibition higher than 90%. Montanine inhibited, in a dose-dependent manner, more than 50% of the enzyme at 1 mM concentration. With the concentrations 500 mu m and 100 mu m, 30-45% of AChE activity inhibition was detected. The alkaloids hippeastrine and pretazettine presented no significant inhibition of the AChE activity. The results demonstrate that montanine significantly inhibits AChE activity at the tested concentrations, suggesting the necessity of further investigations on this alkaloid use in treating neurological disorders. (C) 2009 Elsevier GmbH. All rights reserved.
Subject: Acetylcholinesterase
Amaryllidaceae alkaloids
Country: Alemanha
Editor: Elsevier Gmbh, Urban & Fischer Verlag
Citation: Phytomedicine. Elsevier Gmbh, Urban & Fischer Verlag, v. 17, n. 41890, n. 698, n. 701, 2010.
Rights: fechado
Identifier DOI: 10.1016/j.phymed.2009.10.003
Date Issue: 2010
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
WOS000279656500024.pdf205.88 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.